GO:0051394 regulation of nerve growth factor receptor activity: Signaling Hub, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0051394 describes any process that modulates the frequency, rate or extent of nerve growth factor (NGF) receptor activity, a key signaling node for neurotrophin responses.
• The term centers on NGFR (also known as p75NTR or CD271), a receptor that can trigger survival, apoptosis, or inflammation depending on cellular context and ligand availability.
• Dysregulation of NGFR signaling is implicated in osteoarthritis, germinal center reactions, glioblastoma, triple-negative breast cancer, alcohol use disorders, kidney remodeling, and memory circuits.
• Key genes and proteins in this process include NGF, NGFR, NTRK1, SORT1, BEX3, TRAF6, RIPK2, and downstream effectors such as NF-kB and JNK.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect whether NGFR regulation is causal in disease or merely correlative.
• EDITGENE provides end-to-end cell model and library screening services to study GO:0051394 in physiologically relevant systems.
Description
GO:0051394, regulation of nerve growth factor receptor activity, is a biological process that controls the intensity and duration of signals emanating from the nerve growth factor (NGF) receptor, most prominently NGFR (p75NTR/CD271). This regulatory process is critical because NGFR can couple to diverse intracellular adaptors and produce context-dependent outcomes ranging from cell survival and differentiation to apoptosis and inflammation. Understanding how NGFR activity is tuned is therefore central to neurobiology, immunology, oncology, and regenerative medicine. The QuickGO definition states that this term encompasses any process that modulates the frequency, rate or extent of the activity of the NGF receptor. In practice, regulation occurs through ligand availability, receptor ectodomain shedding, co-receptor interactions, post-translational modifications, and downstream signaling feedback. Researchers studying osteoarthritis have shown that NGFR limits inflammation to promote joint remodeling and repair, illustrating that receptor activity must be tightly regulated for tissue homeostasis. In germinal centers, NGFR regulates stromal cell activation, linking neurotrophin signaling to immune organization. In cancer, NGFR increases tumor growth and metastatic potential in triple-negative breast cancer, while in glioblastoma it is a key player in progression. These findings underscore why GO:0051394 is a high-value target for mechanistic and translational studies.
regulation of nerve growth factor receptor activity At A Glance
| GO ID | GO:0051394 |
|---|---|
| GO term | regulation of nerve growth factor receptor activity |
| Ontology | biological_process |
| Synonym | regulation of NGF receptor activity |
| Definition | Any process that modulates the frequency, rate or extent of the activity of the nerve growth factor (NGF) receptor. |
| Major function | Tuning NGF receptor signaling output in neurons, immune cells, and tumor cells. |
| Key receptor | NGFR (p75NTR/CD271), a member of the TNF receptor superfamily. |
| Primary ligand | Nerve growth factor (NGF), also known as beta-NGF. |
| Associated diseases | Osteoarthritis, glioblastoma, triple-negative breast cancer, alcohol use disorders, kidney remodeling, memory disorders. |
What Is GO:0051394?
In our own words, GO:0051394 refers to any cellular process that adjusts how often, how strongly, or for how long the NGF receptor transmits signals. This includes changes in receptor abundance at the cell surface, ligand-induced activation, co-receptor recruitment, post-translational modifications, and feedback loops that desensitize or amplify receptor output. The term is not limited to a single molecular mechanism; rather, it captures the integrated regulation of NGF receptor activity in physiological and pathological contexts.
Why Is regulation of nerve growth factor receptor activity Important in Cell Biology?
Regulation of NGF receptor activity is important because NGFR sits at the crossroads of neurotrophin signaling, inflammation, and cell fate decisions. When this regulation fails, tissues can experience unchecked inflammation, impaired repair, or malignant progression. For example, NGFR limits inflammation to promote remodeling and repair of osteoarthritic joints, and its loss or dysregulation worsens joint pathology. In germinal centers, NGFR regulates stromal cell activation, influencing immune responses. In cancer, NGFR increases tumor growth and metastatic potential in triple-negative breast cancer and is a key player in glioblastoma progression. In the kidney, neuronally differentiated macula densa cells regulate tissue remodeling and regeneration, a process in which NGF receptor signaling is implicated. In the brain, Ngfr-positive cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory. Thus, understanding GO:0051394 offers mechanistic insight and therapeutic opportunities across diverse organ systems.
• Controls neurotrophin-dependent survival and differentiation of neurons.
• Limits inflammation and promotes repair in osteoarthritic joints.
• Regulates stromal cell activation in germinal centers, linking neurotrophins to immunity.
• Drives tumor growth and metastasis in triple-negative breast cancer.
• Is a key player in glioblastoma progression.
• Modulates alcohol use disorders through NGF signaling.
• Participates in kidney tissue remodeling and regeneration.
• Regulates temporal order recognition memory via cholinergic projections.
• Provides a target for CRISPR-based functional genomics in disease models.
• Informs development of therapies that tune NGFR activity rather than fully inhibit it.
What Happens During regulation of nerve growth factor receptor activity?
Ligand availability and receptor engagement
In simple terms: The process starts when NGF is available to bind the receptor.
Regulation of NGF receptor activity begins with the availability of nerve growth factor (NGF), which can be produced by neurons, immune cells, and stromal cells. NGF binding to NGFR (p75NTR) triggers receptor conformational changes and recruitment of intracellular adaptors. In breast cancer, NGF and pro-NGF expression and signaling pathways have been systematically reviewed, showing that ligand abundance is a key determinant of receptor output. In alcohol use disorders, NGF signaling is altered, further demonstrating that ligand availability modulates receptor activity.
Receptor ectodomain shedding and co-receptor interactions
In simple terms: The receptor can be trimmed or paired with other proteins to change its signal.
NGFR activity is regulated by ectodomain shedding, which releases soluble fragments that can sequester ligand or act as decoys. Co-receptor interactions, such as with NTRK1 (TrkA) or SORT1 (sortilin), switch NGFR signaling from survival to apoptosis or inflammation. In germinal centers, NGFR regulates stromal cell activation, likely through context-dependent co-receptor engagement. These interactions are critical for determining whether NGFR promotes repair or pathology.
Post-translational modifications and adaptor recruitment
In simple terms: Chemical tags on the receptor decide which intracellular proteins are recruited.
Phosphorylation, ubiquitination, and palmitoylation of NGFR modulate its stability and signaling. Adaptor proteins such as TRAF6, RIPK2, and BEX3 are recruited to the NGFR cytoplasmic domain, activating NF-kB, JNK, and other pathways. In triple-negative breast cancer, NGFR increases tumor growth and metastatic potential through such adaptor-dependent signaling. In glioblastoma, NGFR is a key player in progression, with post-translational regulation contributing to its oncogenic functions.
Feedback desensitization and spatial restriction
In simple terms: Cells turn down or localize the signal to avoid overreaction.
Feedback loops involving receptor internalization, degradation, and transcriptional repression desensitize NGFR signaling. Spatial restriction of NGFR to specific membrane domains or cell types, such as Ngfr-positive cholinergic projections from SI/nBM to mPFC, ensures selective regulation of temporal order recognition memory. In osteoarthritic joints, NGFR limits inflammation to promote remodeling and repair, illustrating that feedback and localization are essential for tissue homeostasis. In the kidney, neuronally differentiated macula densa cells regulate tissue remodeling and regeneration, a process that likely involves spatial control of NGF receptor activity.
Key Genes Involved in GO:0051394 regulation of nerve growth factor receptor activity
The following genes and proteins are central to the regulation of nerve growth factor receptor activity (GO:0051394), based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NGF | Primary ligand for NGFR; activates receptor signaling | Target for modulating neurotrophin availability in disease models |
| NGFR | NGF receptor (p75NTR/CD271); central to GO:0051394 | Knockout and overexpression models to test causal roles in cancer and inflammation |
| NTRK1 | TrkA co-receptor; modulates NGFR signaling outcomes | Co-targeting with NGFR in neurotrophin signaling studies |
| SORT1 | Sortilin; co-receptor that influences pro-NGF-induced apoptosis | Knockout models to dissect pro-apoptotic NGFR signaling |
| BEX3 | NGFR-associated adaptor; regulates downstream signaling | Point mutation studies to map adaptor binding sites |
| TRAF6 | E3 ubiquitin ligase; mediates NGFR-induced NF-kB activation | Knockout models to test inflammatory signaling |
| RIPK2 | Kinase adaptor; contributes to NGFR-dependent NF-kB activation | Kinase-dead knock-in to separate signaling branches |
| NFKB1 | Transcription factor downstream of NGFR; drives inflammatory gene expression | Reporter models to monitor NGFR-driven NF-kB activity |
| MAPK8 | JNK kinase; downstream of NGFR in stress and apoptosis | Knockout to test NGFR-JNK axis in disease |
| MAPK9 | JNK kinase; modulates NGFR-dependent apoptosis | Point mutation to alter substrate specificity |
| CASP3 | Executioner caspase; mediates NGFR-induced apoptosis | Knockout to block NGFR-dependent cell death |
| CASP9 | Initiator caspase; downstream of NGFR in intrinsic apoptosis | Overexpression to sensitize cells to NGFR signaling |
| BCL2 | Anti-apoptotic protein; counteracts NGFR pro-apoptotic signals | Overexpression to shift NGFR outcomes toward survival |
| BAX | Pro-apoptotic protein; promotes NGFR-induced apoptosis | Knockout to test dependence on mitochondrial pathway |
| JUN | Transcription factor downstream of JNK; mediates NGFR-driven gene expression | Reporter assays to monitor NGFR-JNK-JUN axis |
| FOS | Immediate early gene; induced by NGFR signaling | Knockout to test role in NGFR-dependent plasticity |
| BDNF | Neurotrophin that can modulate NGFR activity | Overexpression to study cross-talk with NGF signaling |
| NTF3 | Neurotrophin-3; interacts with NGFR in some contexts | Knockout to dissect ligand specificity |
How Is regulation of nerve growth factor receptor activity Regulated?
Regulation of NGF receptor activity is itself controlled by multiple layers of feedback. Ligand availability is modulated by NGF expression, pro-NGF processing, and extracellular proteases. Receptor levels are controlled by transcription, ectodomain shedding, and ubiquitin-mediated degradation. Co-receptors such as NTRK1 and SORT1 shift signaling outcomes. Downstream kinases, including JNK and NF-kB, feed back to modulate receptor expression and sensitivity. In germinal centers, NGFR regulates stromal cell activation, indicating that immune microenvironment cues can regulate receptor activity. In the brain, Ngfr-positive cholinergic projections regulate temporal order recognition memory, suggesting activity-dependent regulation. In osteoarthritic joints, NGFR limits inflammation to promote remodeling and repair, demonstrating that inflammatory signals can feed back on receptor activity. In the kidney, neuronally differentiated macula densa cells regulate tissue remodeling and regeneration, a process that likely involves regulated NGF receptor activity.
regulation of nerve growth factor receptor activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NGFR | Osteoarthritis; limits inflammation and promotes repair | NGFR knockout and overexpression in chondrocytes |
| NGFR | Glioblastoma progression | Patient-derived glioblastoma cells with NGFR knockout |
| NGFR | Triple-negative breast cancer growth and metastasis | Xenograft models with NGFR overexpression or knockout |
| NGFR | Germinal center stromal cell activation | Stromal cell-specific NGFR knockout mice |
| NGFR | Temporal order recognition memory | Ngfr-positive cholinergic projection-specific knockout |
Osteoarthritis and inflammatory joint disease
NGFR limits inflammation to promote remodeling and repair of osteoarthritic joints. Dysregulation of NGF receptor activity can therefore worsen joint pathology. Experimental models using NGFR knockout or overexpression in chondrocytes and synovial cells can test whether modulating receptor activity alters disease progression.
Cancer: glioblastoma and triple-negative breast cancer
NGFR is a key player in glioblastoma progression and increases tumor growth and metastatic potential in triple-negative breast cancer cells. Regulation of NGF receptor activity is thus oncogenic in these contexts. CRISPR knockout and overexpression models can determine whether NGFR activity is required for tumor growth and metastasis.
Immune regulation and germinal center biology
NGFR regulates stromal cell activation in germinal centers. This links NGF receptor activity to immune organization and antibody responses. Knockout and knock-in models can dissect how NGFR signaling in stromal cells shapes germinal center reactions.
Neurological and memory disorders
Ngfr-positive cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory. NGF signaling is also implicated in alcohol use disorders. Regulation of NGF receptor activity is therefore relevant to cognitive and addictive disorders. Conditional knockout and optogenetic models can test causality.
From regulation of nerve growth factor receptor activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is NGFR required for osteoarthritis progression? | NGFR knockout in chondrocytes or synovial cells |
| Does NGFR drive glioblastoma growth? | NGFR knockout in patient-derived glioblastoma cells |
| Does NGFR promote triple-negative breast cancer metastasis? | NGFR overexpression and knockout in xenograft models |
| How does NGFR regulate germinal center reactions? | Stromal cell-specific NGFR knockout mice |
| Does NGFR activity regulate temporal order recognition memory? | Ngfr-positive cholinergic projection-specific knockout |
| Does NGF ligand availability modulate receptor activity? | NGF overexpression or knockout in relevant tissues |
How to Study the regulation of nerve growth factor receptor activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Loss of gene function | Test requirement for NGFR or adaptors in disease models |
| CRISPR knock-in | Precise point mutations | Map signaling domains in NGFR |
| RNA-seq | Transcriptional changes | Identify downstream programs of NGFR activity |
| Proteomics | Protein interactions and modifications | Discover NGFR interactors and post-translational changes |
| Immunofluorescence | Protein localization | Track NGFR shedding and co-receptor interactions |
| NF-kB reporter assay | Inflammatory signaling output | Quantify NGFR-driven NF-kB activation |
| Apoptosis assay | Cell death | Measure NGFR pro-apoptotic signaling |
| Migration assay | Metastatic potential | Test NGFR role in triple-negative breast cancer |
CRISPR knockout and knock-in for causal testing
CRISPR knockout of NGFR or its adaptors (TRAF6, RIPK2, BEX3) can test whether receptor activity is required for disease phenotypes. Knock-in of point mutations in the NGFR cytoplasmic domain can separate signaling branches. These approaches are essential for moving from correlation to causation in GO:0051394 research.
Transcriptomics and proteomics
RNA-seq after NGFR modulation reveals downstream transcriptional programs, including NF-kB and JNK targets. Proteomics can identify NGFR interactors and post-translational modifications. These methods are useful for mapping the regulatory network of GO:0051394.
Imaging and spatial profiling
Immunofluorescence and live-cell imaging can track NGFR localization, shedding, and co-receptor interactions. Spatial profiling in tissues such as osteoarthritic joints, germinal centers, and brain can reveal where receptor activity is regulated. These approaches are critical for understanding spatial restriction of NGFR signaling.
Functional assays for receptor activity
Reporter assays for NF-kB and JNK, apoptosis assays, and proliferation/migration assays measure the functional output of NGFR regulation. These assays can be combined with CRISPR models to quantify how specific perturbations alter receptor activity.
How CRISPR Can Be Used to Study GO:0051394 regulation of nerve growth factor receptor activity
Knockout
CRISPR knockout of NGFR or its downstream adaptors (TRAF6, RIPK2, BEX3) is used to test whether receptor activity is required for phenotypes such as osteoarthritis progression, glioblastoma growth, or breast cancer metastasis. Knockout models are also valuable for dissecting germinal center reactions and memory circuits.
Point Mutation
Point mutations in the NGFR cytoplasmic domain or in adaptor binding sites can separate survival from apoptotic signaling. For example, mutating TRAF6 or RIPK2 binding motifs can block NF-kB activation while preserving other branches. These models are essential for fine-mapping GO:0051394 mechanisms.
Knock-in
Knock-in of tagged NGFR (e.g., HA or GFP) allows tracking of receptor localization, shedding, and interactions in live cells. Knock-in of disease-associated variants can model human phenotypes. These approaches are particularly useful for studying spatial restriction of NGFR activity.
Overexpression
Overexpression of NGFR or NGF can drive tumor growth and metastasis in triple-negative breast cancer and glioblastoma models. Overexpression in chondrocytes or stromal cells can test whether increased receptor activity worsens or ameliorates disease. These models complement knockout studies to establish causality.
How EDITGENE Supports regulation of nerve growth factor receptor activity Research
Researchers studying regulation of nerve growth factor receptor activity-related genes often need to determine whether a candidate gene is causally involved in disease or merely correlative. EDITGENE provides the cell models and screening services required to make that determination with rigor and reproducibility.
Contact EDITGENE today to design your custom CRISPR model for regulation of nerve growth factor receptor activity research.
Frequently Asked Questions About regulation of nerve growth factor receptor activity
What is GO:0051394?
GO:0051394 is the Gene Ontology term for regulation of nerve growth factor receptor activity, defined as any process that modulates the frequency, rate or extent of the activity of the NGF receptor.
What genes are involved in regulation of nerve growth factor receptor activity?
Key genes include NGF, NGFR, NTRK1, SORT1, BEX3, TRAF6, RIPK2, and downstream effectors such as NFKB1 and MAPK8.
What is the function of NGFR in this process?
NGFR (p75NTR/CD271) is the central receptor whose activity is regulated; it can trigger survival, apoptosis, or inflammation depending on context.
How is NGF receptor activity regulated?
It is regulated by ligand availability, ectodomain shedding, co-receptor interactions, post-translational modifications, and feedback desensitization.
Which diseases are linked to regulation of nerve growth factor receptor activity?
Osteoarthritis, glioblastoma, triple-negative breast cancer, alcohol use disorders, kidney remodeling, and memory disorders have been linked to this process.
What experimental models are used to study GO:0051394?
CRISPR knockout, point mutation, knock-in, and overexpression models in chondrocytes, cancer cells, stromal cells, and neurons are commonly used.
Does NGFR promote or inhibit inflammation?
In osteoarthritic joints, NGFR limits inflammation to promote remodeling and repair, but in other contexts it can activate NF-kB and drive inflammation.
How does NGFR affect cancer?
NGFR increases tumor growth and metastatic potential in triple-negative breast cancer and is a key player in glioblastoma progression.
What is the role of Ngfr-positive cholinergic projections?
Ngfr-positive cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory.
How can CRISPR help study regulation of nerve growth factor receptor activity?
CRISPR knockout, knock-in, and overexpression allow causal testing of NGFR and its adaptors in disease models, moving beyond correlation.
Conclusion
GO:0051394, regulation of nerve growth factor receptor activity, is a central biological process that tunes NGFR signaling in health and disease. From osteoarthritis and germinal center biology to glioblastoma, breast cancer, kidney remodeling, and memory, the literature demonstrates that precise control of NGF receptor activity is essential. CRISPR-based models and multi-omics methods provide the tools to dissect this regulation and identify therapeutic opportunities. EDITGENE offers the cell models and screening services needed to advance this research.
References
- 1. Zhao L et al.. 2023. Nerve Growth Factor Receptor Limits Inflammation to Promote Remodeling and Repair of Osteoarthritic Joints.. bioRxiv PMID: 38187570
- 2. Hernández-Barranco A et al.. 2024. NGFR regulates stromal cell activation in germinal centers.. Cell Rep 43(2):113705 PMID: 38307025
- 3. Kidder BM et al.. 2026. Nerve growth factor receptor (NGFR): A key player in glioblastoma progression.. Biochim Biophys Acta Rev Cancer 1881(4):189645 PMID: 42362096
- 4. Ceci FM et al.. 2021. Nerve Growth Factor in Alcohol Use Disorders.. Curr Neuropharmacol 19(1):45-60 PMID: 32348226
- 5. Wu R et al.. 2021. Nerve growth factor receptor increases the tumor growth and metastatic potential of triple-negative breast cancer cells.. Oncogene 40(12):2165-2181 PMID: 33627781
- 6. Gyarmati G et al.. 2024. Neuronally differentiated macula densa cells regulate tissue remodeling and regeneration in the kidney.. J Clin Invest 134(11) PMID: 38598837
- 7. Bruno F et al.. 2022. Expression and Signaling Pathways of Nerve Growth Factor (NGF) and Pro-NGF in Breast Cancer: A Systematic Review.. Curr Oncol 29(11):8103-8120 PMID: 36354700
- 8. Mei F et al.. 2024. Ngfr(+) cholinergic projection from SI/nBM to mPFC selectively regulates temporal order recognition memory.. Nat Commun 15(1):7342 PMID: 39187496
